|
Narcobarbital
|
|
| Systematic (IUPAC) name | |
| 5-(2-bromoprop-2-en-1-yl)-5-isopropyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione | |
| Identifiers | |
| CAS number | |
| ATC code | N01 |
| PubChem | |
| Chemical data | |
| Formula | C11H15BrN2O3 |
| Mol. mass | 303.152 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Narcobarbital (Pronarcon) is a barbiturate derivative invented in the 1960s. It is an N-methylated derivative of Propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.
References
|
|||||
|
||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)




